🔎 Trials Near Me

Akèy › Sistèm Imunitè ak Twoub › Nebraska

Etid klinik pou Sistèm Imunitè ak Twoub nan Nebraska

3 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan Nebraska.

Vil nan Nebraska

Tèks ofisyèl etid la (Anglè)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Nebraska Medicine-Bellevue, Bellevue
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT04242095

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • University of Nebraska Medical Center, Omaha
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Fred and Pamela Buffett Cancer Center, Omaha
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.